Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression
Molecular Oncology · 2026-11 · 20 (11) · 2860-2875
DOI: 10.1002/1878-0261.70208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 19.02.2026. Verfasst von Eileen Wedge und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Denmark. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Mutation, RNA, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Kræftens Bekæmpelse, Lundbeck Foundation.
Abstract (Originalsprache)
Myelodysplastic neoplasms (MDS) are heterogeneous malignancies originating in hematopoietic stem cells. In this explorative study, we carried out ultra‐deep total RNA sequencing on FACS‐sorted CD34+ bone marrow cells from 71 patients and eight healthy age‐matched controls. We investigated the expression of circular RNAs (circRNAs), a group of noncoding RNAs produced by back‐splicing of nonadjacent splice sites. Key findings were further explored in an independent cohort of 118 patients with MDS and ring sideroblasts. circRNA abundance was higher in the disease groups than in controls, and different spliceosome mutations were associated with distinct circRNA expression patterns. Expression of the proliferation‐related gene MKI67 was negatively correlated with circRNA abundance. High circRNA abundance was associated with a significantly increased risk of disease progression at 3 years. The majority of the 38 circRNAs that were significantly upregulated in MDS demonstrated highly correlated expression, and many were associated with risk of leukemic progression. Furthermore, we confirmed the specificity of circZEB1 expression to cases with SF3B1 mutations. We conclude that aberrant circRNA expression is found in MDS and displays associations with disease characteristics and patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Denmark.
- Biotech Research and Innovation Center (BRIC), University of Copenhagen, Denmark.
- Division of Hematology, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Denmark.
- Department of Hematology, Odense University Hospital, Denmark.
ORCID-Profile: Eileen Wedge, Pedro Moura, Jakob Schmidt Jespersen, Krister Wennerberg
Förderung
- Novo Nordisk Fonden
- Kræftens Bekæmpelse
- Lundbeck Foundation
Zitieren
APA
Wedge, E., Tulstrup, M., Todisco, G., Moura, P., Côme, C., Hansen, J. W., Jespersen, J. S., Schlotmann, B., Creignou, M., Dahl, M., Schöllkopf, C., Raaschou-Jensen, K., Wennerberg, K., Porse, B., Weischenfeldt, J., Hellström-Lindberg, E., Kristensen, L. S., & Grønbæk, K. (2026). Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression. Molecular Oncology, 20(11), 2860-2875. https://doi.org/10.1002/1878-0261.70208
Vancouver
Wedge E, Tulstrup M, Todisco G, Moura P, Côme C, Hansen JW, et al. Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression. Molecular Oncology. 2026;20(11):2860-2875. doi:10.1002/1878-0261.70208
BibTeX
@article{Wedge2026,
author = {Wedge, Eileen and Tulstrup, Morten and Todisco, Gabriele and Moura, Pedro and Côme, Christophe and Hansen, Jakob Werner and Jespersen, Jakob Schmidt and Schlotmann, Balthasar and Creignou, Maria and Dahl, Mette and Schöllkopf, Claudia and Raaschou-Jensen, Klas and Wennerberg, Krister and Porse, Bo and Weischenfeldt, Joachim and Hellström-Lindberg, Eva and Kristensen, Lasse Sommer and Grønbæk, Kirsten},
title = {Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {11},
pages = {2860--2875},
doi = {10.1002/1878-0261.70208}
}
EUVIMED